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ABSTRACT 
Objective: The objective of this study was to further examine the relationship of 
associated cardiovascular risk factors and chronic kidney disease (CKD) with a large 
cross-sectional sample of Native Hawaiians, Japanese, Chinese, Filipino, and White 
participants who were enrolled in the National Kidney Foundation of Hawai'i Kidney 
Early Detection Screening (KEDS) program. 
Methods: Data for this cross-sectional study was collected between 2006 and 2009 from 
the National Kidney Foundation of Hawaii (NKFH). Nine hundred and fifteen 
participants who attended the NKFH KEDS program were 18 years and older, and 
residents of the State of Hawaii. Data included demographic information, clinical risk 
factors, anthropometric measurements, and lab values. Microalbuminuria was used as an 
indicator for CKD. - Exploratory analysis using frequencies, means, and standard deviations, chi-square 
tests, and ANOVA were conducted to examine the differences in CVD risk factors and normal and abnormal 
microalbuminuria groups. A multivariate hierarchical logistic regression model was used to 
identify the CV risk factors associated with abnormal microalbuminuria. The Hosmer and 
Lemeshow Goodness of Fit test and R-2-type indices examined the fit of the regression 
model to the data. Results Significant results related to microalbuminuria included BMI 
(p=0.004), glucose (p=.004), and Japanese ethnicity (p=.008). 
Conclusion: The findings support the need to address CVD risk factors in NKFH KEDS 
program. 
Keywords: chronic kidney disease, CVD risk factors, microalbuminuria, Asians, Native 
Hawaiians Pacific Islanders 
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INTRODUCTION 
Approximately 11% of U.S. adults (26 million) have CKD (Chronic Kidney Disease) 
(Centers for Disease Control & Prevention, 2014) and 1 in 3 American adults are at risk for 
developing kidney disease (CDC, 2015). In 2010, the World Health Organization (WHO) 
recognized that CKD was common in people with Cardiovascular Disease (CVD) and associated 
CVD risk factors (i e. diabetes, hypertension, smoking, obesity, dyslipidemia) (Levey et al., 
2007). CVD is the leading cause of morbidity and mortality in patients with CKD followed by 
associated CVD risk factors (Ardhamari, Alpert, & Aggarwal, 2014; Kazancioglu, 2013). Both 
CVD and CKD are closely inter-related to each other (Liu, Li, Lu, Cao et al., 2014). It is also 
known that patients with CKD are at risk of developing CVD and CVD risk factors. These 
studies suggest that the relationship between CKD and CVD is bi-directional (Nashar & Egan, 
2014).  
 Both CVD and CKD share common risk factors such as diabetes, hypertension, obesity, 
dyslipidemia, and smoking which are often under-diagnosed and untreated if not screened early 
(Said & Hernandez, 2014). Diabetes and hypertension are the two major associated CVD risk 
factors of CKD worldwide (Zhang & Rothenbacher, 2008) and are listed as the primary cause for 
7 of 10 new cases of end-stage-renal disease in the U.S. (CDC, 2014). Diabetes is a leading CVD 
risk factor in the U.S. which leads to CKD (CDC, 2014; Saran, Li, Robinson, Avanian et al., 
2015). High blood pressure is the second leading CVD risk factor of CKD. Obesity is associated 
with increased risk of development CKD and may be mediated through CVD risk factors, 
including hypertension, diabetes, and low HDL cholesterol levels (Foster, Hwang, Larson, 
Lichtman et al., 2008). High cholesterol and triglyceride levels have been shown to be 
independent risk factors for progression of CKD (Trevisan, Dodesini, & Lepore, 2006). Smoking 
is also a risk factor for progression of CKD and CV morbidity and mortality in CKD patients 
(Orth & Hallan, 2008).  
 Microalbuminuria is a primary determinant of CKD (Rosansky, 2012; Amin,Whaley-
Connell, Li, Chen et al., 2013) and a major risk factor for the development and progression of 
CKD and CVD (Glassock, 2010; Koroshi, 2007; Tillin, Forouhi, McKeigue, & Chaturvedi, 
2005; Bakris & Molitch, 2014; Jarraya, Lakhdar, Kammoun, Mahfoudh et al, 2013). Studies also 
indicate that microalbuminuria is the most important correlate of systolic hypertension among 
patients with CKD (Agarwal, 2010), is an indicator of insulin resistance and increased renal and 
cardiovascular risk associated with metabolic syndrome (Koroshi, 2007), and suggest that it may 
be a better marker of kidney disease progression than of cardiovascular risk for diabetes, obesity, 
and hypertension (Bentata & Abougal, 2014).  
 The prevalence of kidney failure in Hawaii is 30% higher than the national level 
(Western Pacific Renal Network, 2006) and a larger proportion (88%) of patients on dialysis are 
of Asian and/or Native Hawaiian Pacific Islander (NHPI) ancestry with major ethnic groups 
being Japanese (26.7%), Filipino (24.7%), and Native Hawaiian (17%) (U.S. Renal Data System, 
2013). The percentage breakdown of the State of Hawaii population based on Japanese, Filipino, 
and Native Hawaiians is 16.7%, 14.1%, and 6.6 %, respectively (U.S. Bureau of Census, 2014). 
In Hawaii, it is estimated that over 156,000 individuals have CKD and another 100,000 are at 
risk (almost 20% of the population) (CDC, 2007). Studies of large national data on Asian and 
NHPI populations and CKD are sparse and often data is aggregated or placed in the "other" 
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category. The prevalence of CKD in Hawaii has continued to rise due in part to rates of diabetes, 
hypertension, obesity, and CKD reported in this population (Mau, West, Sugihara, Kamaka et al.,  
2003; Mau, West, Shara, Efird et al., 2007). King, McNeely, Thorpe, Mau et al. (2012) examined 
the National Health Interview Survey prevalence of type 2 diabetes in Asian American NHPI 
populations and found the odds of prevalence of diabetes adjusting for age and sex was 40% 
higher in Asian Americans relative to Whites. More specifically, there was a significant 
association between diabetes and CKD among Filipinos and Native Hawaiians (Mau, West, 
Shara, Efird et al., 2007). Native Hawaiians have a fourfold greater age-adjusted prevalence rate 
for type 2 diabetes (Grandinetti, Chang, Mau, Curb et al., 1998). Almost 1 in 5 of Asians and 
NHPIs also have hypertension (American Kidney Fund, 2015) and hypertension has been 
associated with CKD among four of the five ethnic groups (Japanese, Native Hawaiian, Filipino, 
and Whites) (Mau, West, Shara, Efird et al., 2007). Native Hawaiian/Part Hawaiian ethnicity 
have the highest mean BMI for men and women in comparison to other ethnic groups in Hawaii 
(Moy, Sallis, & David, 2010; Mau, West, Shara, Efird et al., 2007).  
 In 2005, the National Kidney Foundation of Hawaii (NKFH) developed the Kidney Early 
Detection Screening (KEDS) program to raise awareness about individual risk for kidney disease 
and conducted early screenings in the rural and urban communities in the State. The KEDS 
program was adapted from a national program called Kidney Early Evaluation Program (KEEP). 
A formative program evaluation of the NKFH KEDS program was completed in 2012 and over 
1,000 participant data was collected and descriptive results were reported (Kataoka-Yahiro, 
Wong, Page, Tamashiro et al., 2012).  
 The unique contribution of KEDS was the use of disaggregated Asian and NHPI data not 
reported in the Kidney Early Evaluation Program (KEEP) (National Kidney Foundation, 2009). 
The majority of KEDS participants were between the ages of 46 and 75 years of age, primarily 
women. White, Japanese, Chinese, Filipino, and Hawaiian/Part Hawaiian were most represented. 
Participants had an average of one or two risk factors out of the seven total risk factors. The three 
most identified individual risk factors included: (1) blood relative with diabetes, (2) blood 
relative with cardiovascular disease, and (3) self-reported high blood pressure. Ethnicity was 
significantly associated with BMI and Hawaiian/Part Hawaiian ethnicity had a higher value of 
BMI than other ethnicities. 
Objective 
The objective of this study was to further examine the relationship of associated 
cardiovascular risk factors and CKD with a large cross-sectional sample of Native Hawaiians, 
Japanese, Chinese, Filipino, and White participants who were enrolled in the National Kidney 
Foundation of Hawai'i Kidney Early Detection Screening (KEDS) program. 
 
METHODS 
Design  
This was a cross-sectional study on National Kidney of Foundation of Hawaii (NKFH) 
(KEDS) data collected between 2006 and 2009. The study was approved by the University of 
Hawaii at Manoa, Human Studies Program. CHS # is 19344.  
Sample  
This study included 915 participants who were enrolled in a KEDS screening program, 
were 18 years and older, and residents of the State of Hawaii. This was a free screening program 
20 Relationship of Associated Cardiovascular Risk Factors and Chronic Kidney Disease with 
Participants Enrolled in the National Kidney Foundation of Hawai'i Kidney Early Detection 
Screening (KEDS) Program  
 Kataoka-Yahiro et al. 
 
Journal of Health Disparities Research and Practice Volume 9, Issue 4 Winter 2016 
 http://digitalscholarship.unlv.edu/jhdrp/   
offered by the National Kidney Foundation of Hawaii to cast a "wider net" by reaching those 
possibly at risk for CKD who may not have seen a primary care provider. The participants 
attended one of the 14 KEDS events held in the State in both urban and rural areas of the State. 
The KEDS sites included shopping malls, community colleges, community health centers, 
hospitals, community centers, and the Hawaii State Capitol. 
Measures 
Demographic information included gender, age, ethnicity, zipcode, and individual/total 
risk factors. Clinical risk factors included a medical history of diabetes, hypertension, 
hypercholesterolemia, a family history of diabetes, cardiovascular disease, or kidney disease, or a 
social history of cigarette smoking. Anthropometric measurements included blood pressure (BP), 
height, weight, body mass index (BMI) and lab values (ie. glomerular filtration rate, fasting and 
non-fasting glucose, levels, total cholesterol, urine microalbuminuria, and albumin to creatinine 
ratio (A:C ratio) were obtained. Microalbuminuria was used as an indicator for CKD with 30 
mg/L or greater being the cut off for reporting possible kidney damage.  
Data collection  
Approximately 25 to 45 volunteers were trained and participated at each event. Every 
volunteer participated in an orientation which included: (a) screening purpose and program 
procedures, (b) paperwork and documentation, (c) interviewing techniques, (d) equipment 
protocols for blood testing, (e) physical measurements, (f) urinalysis, and (g) screening follow-
up recommendations..  
 A typical KEDS event consisted of five stations - Registration, Physical Measurements, 
Urinalysis, Blood Draw, and Exit Interview. Participants signed a consent form and then 
completed the assessment form. Professional volunteers or students performed blood pressure 
readings and height and weight measurements. Blood pressure readings were measured using 
Welch-Allyn Spot Vital Signs (420 Series) BP monitor, and a Tanita BWB-800 digital weight 
scale. BP cuffs were fitted for proper arm size and clothing was removed on the left or right 
upper arm. Volunteers provided participants with a specimen cup and instructions to provide a 
"clean-catch" urine sample. Specimens were processed utilizing either a Clinitek 50 or Clinitek 
Status Analyzer and Bayer/Siemens Diagnostics Microalbumin Reagent test strips were used. 
Capillary blood specimens were completed using Accu-Check Aviva blood glucose meters and 
test strips by Roche. Venous or capillary blood specimens were collected by professionals skilled 
in phlebotomy and specimens were transported by couriers to local laboratories for processing.  
Health professionals (Registered Nurse, Advanced Practice Nurse) conducted brief 5 to 10 
minute interviews with participants and reviewed screening results. General recommendations 
and education regarding risk factors for CKD were also provided. Participants with abnormal 
results were advised to follow-up with their primary care providers. Venous blood specimen 
results were mailed to the participants' homes seven to ten days after the screening.  
  Participant demographic data collected included gender, age, ethnicity, zipcode, and risk 
factors. Clinical risk factors were collected medical history of diabetes, hypertension, 
hypercholesterolemia, family history of diabetes, cardiovascular disease, or kidney disease, or 
social history of cigarette smoking. Anthropometric measures including measurements of blood 
pressure (BP), height, weight, body mass index (BMI), and lab values (i e. glomerular filtration 
rate (GFR), fasting and non-fasting glucose levels, total cholesterol, urine microalbuminuria, and 
albumin to creatinine ratio [A:C ratio] were obtained.  
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Data analysis 
Frequency distributions and summary statistics were used to describe the characteristics 
of participants. Chi-square tests and one-way ANOVA were used to examine the differences in 
CVD risk factors for normal and abnormal microalbuminuria groups. A hierarchical logistic 
regression model was applied to the KEDS screening data to identify the risk factors associated 
with abnormal microalbuminuria. The effects of demographic characteristics (age, gender, 
ethnicity (Hawaiian/Part-Hawaiian, Japanese, Chinese, Filipinos, White), history of diabetes, 
hypertension, high cholesterol, smoking) were analyzed first to describe the study group. Then 
the basic biometrical measurements (glucose, upper and lower blood pressure, BMI) were added 
to the model to examine their effects on microalbuminuria after adjusting the effects of 
demographic variables. All statistical analyses were conducted in IBM SPSS Statistics for 
Windows (SPSS Statistics for Windows, Version, 20.0, 2011). The significance level for all tests 
was set at 5%. The Hosmer and Lemeshow goodness of fit test and R2-type indices were used to 
examine the fit of the hierarchical logistic regression model to the data.  
 
RESULTS 
 The majority of the participants in the screening program were females (62.4%) with the 
mean age of around 55 years old. Almost half of the participants were Asian-American 
(Japanese-American (23.3), Filipino-American) (18.1%), Chinese-American (7.2%)), followed 
by Hawaiian/Part Hawaiian/Mixed (26.0%) and White (25.4%). The sample of African-
American and Native American were not included in this study due to a very small sample size < 
.01%. About 39.2% of the participants had hypertension with a mean systolic blood pressure of 
127 and mean diastolic blood pressure of 76. Twenty percent of the participants had diabetes 
with a mean glucose level at 113. The mean BMI for participants attending the screening was 
27.3 (see Table 1). 
 
Table 1: Demographics of participants (n=915) 
Variable  n 
Gender Male 336 (37.6%) 
 Female 558 (62.4%) 
Ethnicity White 198 (25.4%) 
 Hawaiian/Part Hawaiian 203 (26.0%) 
 Japanese 182 (23.3%) 
 Filipino   141 (18.1%) 
 Chinese    56 ( 7.2%) 
 Missing   135(14.8%)  
Hypertension* Yes 359 (39.2%) 
 No 556 (60.8%) 
Diabetes** Yes 185 (20.2%) 
 No 730 (70.8%) 
Cholesterol*** Yes 265 (29.9%) 
 No 650 (71.0%) 
Smoking# Yes 5.1 (5.1%) 
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 No 868 (94.9%) 
   
 Mean SD 
Age (Years, n=847) 55.3 16.4 
Systolic BP (n=893)**** 127.3 17.8 
Diastolic BP (n=893)^ 76.2 10.0 
BMI (n=893)++ 27.3 6.5 
Glucose (n=794)+++ 113.00 44.5 
*Hypertension: USDHHS NIH. (2004). The Seventh Report of the Joint National Committee on 
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: Complete 
Report. 
**Diabetes: National Kidney Foundation. (2003). KEEP Results Explanation Sheet for screening 
participants. 
***Cholesterol: National Kidney Foundation.(2010). About KEEP, Understanding Test Values 
#Smoking: Social History of Cigarette Smoking  
****Systolic BP: Chobanian A., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, 
J.L., Jr., Jones, D.W., Materson, B.J., Oparil, S., Wright, J.T., Jr., Roccella, E.J. (2003). 
National Heart, Lung, and Blood Institute Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood 
Pressure Education Program Coordinating Committee. The Seventh Report of the Joint 
National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood 
Pressure: The JNC 7 report. JAMA, 289 (19), 2560-2572.  
****Systolic BP: USDHHS NIH. (2004). The Seventh Report of the Joint National Committee 
on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure-Complete 
Report.  
^ Diastolic BP: change reference to Martinson, M.L., Teitler, J.O., & Reichman, N.E. (2011). 
Health across the lifespan in the U.S. & England. American Journal of Epidemiology, 
173 (3), 858-865 
++BMI: CDC. About BMI for Adults. (2010).  
www.cdc.gov.healthyweight/assessing/bmi/adult_bmi/index 
+++Glucose: National Kidney Foundation. (2003). KEEP results explanation sheet for screening 
participants. 
 
 Microalbuminuria was used as an indicator for CKD. A 30mg/L or greater 
microalbuminuria indicates possible CKD. Pearson chi-square tests were performed to compare 
the differences between the group with normal microalbuminuria (n=426) and those with 
abnormal microalbuminuria (30 mg/L or greater) (n=438). Forty-nine percent of the sample had 
normal microalbuminurea results and 51% had abnormal results.  
 Pearson chi-square test and one-way ANOVA were used to test the differences in CVD 
risk factors for normal and abnormal microalbuminuria groups. There was no gender or ethnic 
differences in the proportion of abnormal microalbuminuria. Participants with diabetes had a 
significantly higher proportion of abnormal microalbuminuria (p =0.00) and participants with 
high blood pressure, high cholesterol, and history of smoking were not significant when 
compared with abnormal microalbuminuria. The mean age and diastolic blood pressure were not 
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significantly different between participants with normal microalbuminuria and participants with 
abnormal microalbuminuria. Participants with abnormal microalbuminuria were significantly  
higher in systolic blood pressure (p=0.00), BMI (p=0.00), and glucose level (p=0.00) compared 
to participants with normal microalbuminuria (see Table 2). 
 
Table 2: Difference in CKD and CVD risk factors for normal and abnormal microalbuminuria 
groups (n=915) 
Variable  Normal 
Microalbuminuri
a 
<30mg/L 
(n=426) 
Abnormal 
Microalbuminuria 
≥30mg/L 
(n=438) 
Chi-
Square 
test 
p-
value 
Gender Male 159 167  0.05 0.83 
 Female 261 266   
Ethnicity White 108  78  7.68 0.10 
 Hawaiian/ 
Part 
Hawaiian 
 87 104   
 Japanese  83  94   
 Chinese  24  30   
 Filipino  67  69   
Hypertension Yes 155 183  2.64 0.10 
 No 271 255   
Diabetes Yes  62 113 16.91 0.00* 
 No 364 325   
Cholesterol 
  
Smoking                  
Yes 
No   
Yes 
No                  
112 
314 
 29 
397 
138 
300 
 18 
420 
 2.85 
 
 3.05 
0.09 
 
0.08 
 
 
 
 
 
N n  n  One-
way 
ANOVA 
p-
value 
Age (Years) 811 398 (49.1%)  413 (50.9%)   3.31 0.07 
Systolic BP  856 425 (49.6%)  431 (50.4%)   8.78 0.00* 
Diastolic BP  856 425 (49.6%)  431 (50.4%)   0.13 0.71 
BMI 854 422 (49.4%)  432 (50.6%)  16.15 0.00* 
Glucose 753 360 (47.8%)  393 (52.2%)  22.64 0.00* 
 
 Multivariate logistic regression model (n=594) was used to fit the data to identify CVD 
risk factors for CKD. BMI (p=0.004), Glucose (p=0.004), and Japanese ethnicity (p=0.008) 
compared to other racial/ethnic groups were significantly associated with abnormal 
microalbuminuia after adjusting the effects of all other variables in the model. Participants with  
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higher BMI and higher glucose levels were more likely to have abnormal microalbuminuria. No 
significant interactions were found between all these risk factors (see Table 3).  
 
Table 3: Logistic Regression Model on Factors Related to CKD (n=594) 
Predictor   B S.E. of B Wald’s  df p-value 
Age .003 .006 .191 1 .662 
Gender .098 .181 .297 1 .586 
Ethnicity-White   7.664 4 .105 
Hawaiian/Part 
Hawaiian 
.409 .253 2.605 1 .107 
Japanese .673 .254 7.022 1  .008* 
Chinese .546 .371 2.174 1 .140 
Filipino .313 .271 1.341 1 .247 
Hypertension .033 .204 .026 1 .872 
Diabetes -.140 .251 .311 1 .577 
Cholesterol         .022 .202 .012 1 .914 
Smoking 
Systolic BP 
.548 
.010 
.381 
.007 
2.067 
2.246 
1 
1 
.150 
.134 
Diastolic BP -.014 .012 1.511 1 .219 
BMI .046 .016 8.395 1 .004* 
Glucose .007 .002 8.311 1 .004* 
 
The Hosmer and Lemeshow tests showed a reasonable goodness of fit of the hierarchical 
model. The Cox and Snell R Square indicated 7.5% of variability of the data could be explained 
by the hierarchical logistic regression model (see Table 4).  
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Table 4: Logistic Regression Model Evaluation and Goodness of Fit Statistics (n=594) 
Test R-Square  df p-value 
Overall model evaluation     
Cox & Snell R Square .075    
Nagelkerke R Square .100    
Goodness of Fit     
Hosmer and Lemeshow Test  7.400 8 .494 
 
DISCUSSION 
 In this secondary data analysis, abnormal microalbuminuria was significant for having a 
high BMI, high glucose, and being of Japanese ethnicity, independent of each other. There are 
very few CVD risk factors and CKD U.S. studies in which only one ethnic Asian and NHPI 
group are studied and many of the studies have originated in Japan. Ogata, Yorioka, Gilbertson, 
Chen et al. (2009), a cross-cultural study, compared the U.S. Renal Data System data and the 
Japanese Society for Dialysis Therapy data from 1983 to 2002 and found survival rates were 
better for Japanese versus U.S. Japanese Americans. In this study, Japanese-Americans were 
older, male, and had a higher rate of diabetes and hypertension and died more often of heart 
failure than other U.S. groups. When compared to other Japanese groups, there were more 
Japanese-Americans in Hawaii with diabetes and hypertension. Mau, West, Shara, Efird et al. 
(2007) examined the association between key factors and measures of CKD in 793 Asian 
American and Native Hawaiian participants enrolled in KEEP-2 study (2001-2003). CKD was 
defined as the estimated glomerular filtration rate (EGFR) or random urine microalbuminuria. 
Disaggregated data on Japanese, Native Hawaiian, Chinese, Filipino, and Whites were analyzed 
and the overall independent associated CVD risk factors of CKD were diabetes and 
hypertension. In this study, Japanese had the lowest prevalence of CKD (18%) and Native 
Hawaiians had the highest (40%). The authors concluded that genetic and environmental factors 
may affect patient outcomes. 
  Our study results also indicated that participants are at risk for CKD if they have a higher 
BMI and higher glucose, independent of each other and are well-referenced indicators of obesity 
and or diabetes. Ohno, Ishimura, Naganuman, Kondo et al. (2012) found among their Japanese 
patients, diabetes and obesity were independently associated with CKD. Nagata, Ninomiya, Doi, 
Yonemoto et al. (2010) investigated further the trends in prevalence of risk factors and CKD in 
the general Japanese population. They found that diabetes, hypercholesterolemia, and obesity 
increased over three decades. The Global Burden of Metabolic Risk Factors for Chronic Diseases 
Collaboration (2014) group investigated cardiometabolic risk factors in international countries 
from 1980 to 2010 and found that the mortality burden of high BMI and glucose nearly doubled 
from 1980 to 2010 and has shifted from high-income to low-income and middle-income 
countries. Matsushita, Yasuda, Shouda, Umemura et al. (2009) found obesity was an 
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independent risk factor for CKD and proteinuria even among healthy Japanese patients 40 years 
of age and younger.  
 The current study results add to the existing body of literature since Mau et al. (2007) by 
using a large kidney data set to disaggregate and examine the relationship CV risk factors and 
CKD. In comparison to the KEEP Program (2009), the authors in the KEDS program 
disaggregated the Asians and NHPIs by various subgroups such as Native Hawaiians, Japanese, 
Chinese, Filipino, and Whites versus categorizing and reporting the Asians and NHPI groups in 
the "Other" category. There is an imperative need to address health disparities by conducting 
disaggregated large population studies which target ethnic minority populations. This activity 
will capture the unique demographic and social characteristics and care needs related to 
individual subgroups of Asians and NHPI populations in CKD research and practice.              
  The limitations of this study was that it was a cross-sectional study utilizing a 
convenience sample in Hawaii. Participants self-selected to be in this study and the sample was 
situated in one geographic island state which may not be representative of the general 
population. The low R-square values from the logistic regression may indicate other factors 
related to CKD were not included such as specific lab work - fasting glucose, lipid levels - LDL, 
HDL, triglycerides, and eGFR. These lab values were not included in the logistic regression 
model due to a small n. The screening questionnaire did not include questions on diet and 
physical activity, which may be interesting to add in future KEDS screening. An R-square of 
10% or less could still provide valuable information when looking for a relationship between 
predictor variables and outcome (Cox & Snell, 1989; Kvalseth, 1985). Finally, an investigation 
of the effects of CKD risk factors on different race/ethnic groups is also worthy to pursue in 
future studies. 
 
CONCLUSION 
 Though there are limitations of this study, the findings were consistent with studies 
reported in the literature and supported the need for CVD risk factor screening in the NKFH 
KEDS program. Understanding the relationship between CVD risk factors and CKD is important 
in developing future public health policy to improve outcomes. It is important to continue to 
examine large sample disaggregate data of racial/ethnic minority populations in order to identify 
CVD risk factors targeted to culturally appropriate screening, detection, referral, and 
intervention. More specifically, targeted kidney programs should include screening, detection, 
referral, and education for associated CVD risk factors in routine kidney screening and 
distinguish CVD risk factors to different stages of CKD, taking into consideration age, 
race/ethnicities, and gender in efforts to improve health outcomes.  
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